Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA567078
Max Phase: Preclinical
Molecular Formula: C64H80N12O12
Molecular Weight: 1209.42
Molecule Type: Small molecule
Associated Items:
ID: ALA567078
Max Phase: Preclinical
Molecular Formula: C64H80N12O12
Molecular Weight: 1209.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N=C(NCCCCCNC(=O)CNC(=O)CNC(=O)CCC(=O)NCC(=O)NCC(=O)N[C@H]1C[C@@H]2Oc3c(O)ccc4c3[C@@]23CCN(CC2CC2)[C@H](C4)[C@]3(O)C1)Nc1ccc2[nH]c3c(c2c1)C[C@@]1(O)[C@H]2Cc4ccc(O)c5c4[C@@]1(CCN2CC1CC1)[C@H]3O5
Standard InChI: InChI=1S/C64H80N12O12/c65-60(73-38-10-11-42-40(24-38)41-27-64(86)46-23-37-9-13-44(78)58-55(37)62(64,59(88-58)56(41)74-42)17-21-76(46)33-35-6-7-35)67-19-3-1-2-18-66-50(81)28-70-51(82)29-68-48(79)14-15-49(80)69-30-52(83)71-31-53(84)72-39-25-47-61-16-20-75(32-34-4-5-34)45(63(61,85)26-39)22-36-8-12-43(77)57(87-47)54(36)61/h8-13,24,34-35,39,45-47,59,74,77-78,85-86H,1-7,14-23,25-33H2,(H,66,81)(H,68,79)(H,69,80)(H,70,82)(H,71,83)(H,72,84)(H3,65,67,73)/t39-,45+,46+,47-,59-,61+,62-,63+,64+/m0/s1
Standard InChI Key: FIXIYOMFMSRPBS-OWULCGSXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1209.42 | Molecular Weight (Monoisotopic): 1208.6019 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zhang S, Yekkirala A, Tang Y, Portoghese PS.. (2009) A bivalent ligand (KMN-21) antagonist for mu/kappa heterodimeric opioid receptors., 19 (24): [PMID:19892550] [10.1016/j.bmcl.2009.10.045] |
Source(1):